
Docking studies of derivates of phenylaminopyrimidines (PAP) as SARS-Cov-2 main protease inhibitors
Author(s) -
Carlos J. CortésGarcía,
Carlos J. CortésGarcía,
Valeria Muñoz-Gutiérrez,
Ma. Guadalupe Villa-Lopez,
Claudia Contreras-Celedón,
Luis Chacón García
Publication year - 2020
Language(s) - English
Resource type - Conference proceedings
DOI - 10.3390/ecsoc-24-08330
Subject(s) - protease , imine , chemistry , ligand (biochemistry) , in vitro , covid-19 , docking (animal) , stereochemistry , enzyme , receptor , biochemistry , medicine , catalysis , nursing , disease , pathology , infectious disease (medical specialty)